A carregar...
Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review
INTRODUCTION: Immunotherapies, including checkpoint inhibitors (CIs) such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) inhibitors, are revolutionizing the treatment of advanced melanoma. Combining CTLA-4 and PD-1 inhibitors provides additional clinical benefit compared...
Na minha lista:
| Publicado no: | Melanoma Manag |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6122526/ https://ncbi.nlm.nih.gov/pubmed/30190927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2017-0027 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|